Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Altered miRNA processing disrupts brown/white adipocyte determination and associates with lipodystrophy
Marcelo A. Mori, … , Aaron M. Cypess, C. Ronald Kahn
Marcelo A. Mori, … , Aaron M. Cypess, C. Ronald Kahn
Published July 1, 2014
Citation Information: J Clin Invest. 2014;124(8):3339-3351. https://doi.org/10.1172/JCI73468.
View: Text | PDF
Research Article Metabolism

Altered miRNA processing disrupts brown/white adipocyte determination and associates with lipodystrophy

  • Text
  • PDF
Abstract

miRNAs are important regulators of biological processes in many tissues, including the differentiation and function of brown and white adipocytes. The endoribonuclease dicer is a major component of the miRNA-processing pathway, and in adipose tissue, levels of dicer have been shown to decrease with age, increase with caloric restriction, and influence stress resistance. Here, we demonstrated that mice with a fat-specific KO of dicer develop a form of lipodystrophy that is characterized by loss of intra-abdominal and subcutaneous white fat, severe insulin resistance, and enlargement and “whitening” of interscapular brown fat. Additionally, KO of dicer in cultured brown preadipocytes promoted a white adipocyte–like phenotype and reduced expression of several miRNAs. Brown preadipocyte whitening was partially reversed by expression of miR-365, a miRNA known to promote brown fat differentiation; however, introduction of other miRNAs, including miR-346 and miR-362, also contributed to reversal of the loss of the dicer phenotype. Interestingly, fat samples from patients with HIV-related lipodystrophy exhibited a substantial downregulation of dicer mRNA expression. Together, these findings indicate the importance of miRNA processing in white and brown adipose tissue determination and provide a potential link between this process and HIV-related lipodystrophy.

Authors

Marcelo A. Mori, Thomas Thomou, Jeremie Boucher, Kevin Y. Lee, Susanna Lallukka, Jason K. Kim, Martin Torriani, Hannele Yki-Järvinen, Steven K. Grinspoon, Aaron M. Cypess, C. Ronald Kahn

×

Figure 4

Characterization of inducible fat–specific Adicer-KO (iaP2dicer-KO) mice.

Options: View larger image (or click on image) Download as PowerPoint
Characterization of inducible fat–specific Adicer-KO (iaP2dicer-KO) mice...
Mice carrying the Cre recombinase gene driven by a tamoxifen-induced aP2 promoter or their littermate Lox controls were given 3 mg tamoxifen weekly from 3 to 8 months of age (n = 6–7 mice per group). (A) Expression of dicer mRNA as assessed by qPCR. (B–D) Tissue weights normalized to body weight for (B) interscapular BAT, (C) WAT depots, and (D) nonadipose tissues. (E) UCP1 expression in interscapular BAT. β-Tubulin was used to control for protein concentration. The β-tubulin immunoblot was performed with samples run on a separate gel. (F) ITT using i.p. injection of 1 U insulin/kg body weight. *P < 0.05. Values are the mean ± SEM. SQ fat, subcutaneous WAT of the flank region; SS fat, subcutaneous WAT of the suprascapular region; BAT, interscapular BAT; PG fat, perigonadal (epididymal) WAT; RP fat, retroperitoneal WAT; Quad, quadriceps skeletal muscle.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts